Skip to main content
. 2022 Nov 29;66(12):e00564-22. doi: 10.1128/aac.00564-22

FIG 2.

FIG 2

(A to C) Time-kill kinetics of gepotidacin in combination with (A) (i) linezolid, (ii) moxifloxacin, and (iii) meropenem against M. fortuitum ATCC 6841, with (B) (i) amikacin and (ii) moxifloxacin against M. abscessus ATCC 19977 and with (C) isoniazid against M. tuberculosis ATCC 27294.